Astellas sues Japanese rival over Myrbetriq generic

18-10-2016

Astellas sues Japanese rival over Myrbetriq generic

Tashatuvango / shutterstock.com

Japanese pharmaceutical company Astellas has filed a complaint against another Japanese company, Sawai Pharmaceutical, for allegedly infringing its patents centring on the drug Myrbetriq (mirabegron).


Astellas, Sawai, Myrbetriq, patent, ANDA, FDA

LSIPR